UBC9 Antibodies

Santa Cruz Biotechnology features a diverse variety of UBC9 monoclonal antibodies for research in understanding UBC9's role in cellular processes. UBC9 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA) applications.UBC9, also known as Ubiquitin-Conjugating Enzyme 9, is a critical enzyme involved in the SUMO (Small Ubiquitin-like Modifier) modification pathway, which regulates numerous cellular functions such as gene expression, DNA repair, and cell cycle progression. The proper functioning of UBC9 is essential for maintaining cellular homeostasis and responding to stress signals. Dysregulation of UBC9 has been implicated in various diseases, including cancer, making it a significant target for therapeutic research. UBC9 plays a vital role in post-translational modifications and protein trafficking within cells. Research has shown that UBC9 expression levels can vary significantly across different tissue types and developmental stages. Understanding UBC9's interaction with other proteins provides valuable insights into cellular regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of UBC9's role in health and disease.